- Home
- SWIN vs CLGN Comparison
SWIN vs CLGN Comparison
Compare SWIN & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- CLGN
- Stock Information
- Founded
- SWIN 2017
- CLGN 2004
- Country
- SWIN Hong Kong
- CLGN Israel
- Employees
- SWIN N/A
- CLGN 57
- Industry
- SWIN
- CLGN Industrial Specialties
- Sector
- SWIN
- CLGN Health Care
- Exchange
- SWIN Nasdaq
- CLGN Nasdaq
- Market Cap
- SWIN 32.1M
- CLGN 22.1M
- IPO Year
- SWIN 2023
- CLGN N/A
- Fundamental
- Price
- SWIN $1.71
- CLGN $3.18
- Analyst Decision
- SWIN
- CLGN Strong Buy
- Analyst Count
- SWIN 0
- CLGN 2
- Target Price
- SWIN N/A
- CLGN $11.50
- AVG Volume (30 Days)
- SWIN 193.7K
- CLGN 165.3K
- Earning Date
- SWIN 06-10-2025
- CLGN 05-28-2025
- Dividend Yield
- SWIN N/A
- CLGN N/A
- EPS Growth
- SWIN N/A
- CLGN N/A
- EPS
- SWIN N/A
- CLGN N/A
- Revenue
- SWIN $2,419,000.00
- CLGN $2,472,000.00
- Revenue This Year
- SWIN N/A
- CLGN $2,177.67
- Revenue Next Year
- SWIN $61.68
- CLGN $56.52
- P/E Ratio
- SWIN N/A
- CLGN N/A
- Revenue Growth
- SWIN N/A
- CLGN N/A
- 52 Week Low
- SWIN $1.16
- CLGN $1.55
- 52 Week High
- SWIN $5.33
- CLGN $5.63
- Technical
- Relative Strength Index (RSI)
- SWIN 50.70
- CLGN 59.91
- Support Level
- SWIN $1.43
- CLGN $1.90
- Resistance Level
- SWIN $1.78
- CLGN $4.98
- Average True Range (ATR)
- SWIN 0.18
- CLGN 0.40
- MACD
- SWIN -0.03
- CLGN 0.25
- Stochastic Oscillator
- SWIN 59.68
- CLGN 47.52
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.